Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies
Adam J. Savitz1, Haiyan Xu1, Srihari Gopal1, Isaac Nuamah1, Maju Mathews2, Bernardo Soares3
DOI: 10.1590/1516-4446-2018-0153
Vol.41 Issue 6/2019: